Michael T. Sweeney
Chief Tech/Sci/R&D Officer at RESVERLOGIX CORP.
Net worth: 6 523 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Donald McCaffrey | M | - | 24 years | |
| Douglas Lankler | M | 58 | 25 years | |
| Kenneth Zuerblis | M | 64 | 14 years | |
| Kelly McNeill | M | 54 | 15 years | |
| Ewelina Kulikowski | M | - | 19 years | |
| Siu Lun To | M | 55 | - | |
| Anthony Cann | M | 76 | 15 years | |
| Suneet Varma | M | 55 | 23 years | |
| Payal Sahni Becher | F | - | 27 years | |
| Mike McDermott | M | 58 | 21 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jeffrey Kindler | M | 68 | 8 years | |
| Henry McKinnell | M | 81 | 8 years | |
| Julian N. Stern | M | 99 |
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | 18 years |
| Peter Johann | M | 67 | 7 years | |
| James Schoeneck | M | 66 |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | 10 years |
| August Moretti | M | 73 |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | 6 years |
| George A. Lorch | M | 82 | 15 years | |
| Craig R. Smith | M | 77 |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | 9 years |
| Dana George Mead | M | 88 | 12 years | |
| Michael Brown | M | 83 | 16 years | |
| Peter Corr | M | 76 | 6 years | |
| Vicente J. Anido | M | 71 |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | 3 years |
| Christopher Chai | M | 58 |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 8 years |
| Jennifer Schroeder | F | - | 20 years | |
| Norma Biln | F | - | - | |
| Eldon Smith | M | 84 | 9 years | |
| Everett Cunningham | M | 57 | 9 years | |
| Norman Wong | M | - | 22 years | |
| Jonathan Emms | M | - | 20 years | |
| George Milne | M | 80 | 32 years | |
| Louis Lavigne | M | 75 |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | 6 years |
| Martin MacKay | M | 68 | 14 years | |
| Paul Fitzhenry | M | 64 | 4 years | |
| Karen Dawes | F | 72 |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | - |
| Michael R. Jirousek | M | 65 | 5 years | |
| Jeff P. Coon | M | 61 |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | 6 years |
| William Herbert Gray | M | 82 | 13 years | |
| Joseph M. Danis | M | - | 10 years | |
| Olivier Brandicourt | M | 68 | 13 years | |
| Gerd Kochendoerfer | M | 56 |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | - |
| Alexandra Kropotova | M | 51 | 5 years | |
| Paul Moon | M | - | - | |
| Wyllie Cornwell | M | 76 | 23 years | |
| Robert N. Burt | M | 86 | 11 years | |
| Franklin Raines | M | 74 | 11 years | |
| Joseph Monahan | M | 69 | 7 years | |
| David Simmons | M | 59 | 16 years | |
| Richard Paulson | M | 56 | 9 years | |
| Mariano García-Valiño | M | 58 | 8 years | |
| Fei He | M | 55 | 7 years | |
| David J. Wustrow | M | 65 | 2 years | |
| Howard Donnelly | M | 63 | 9 years | |
| Michael Bruce | M | - | 12 years | |
| Baiyong Li | M | 56 | 12 years | |
| Feng Guo | M | 54 | 11 years | |
| Angela Hwang | F | 58 | 26 years | |
| Dawn Rogers | F | 59 | - | |
| John Chapman | M | 70 | 4 years | |
| Christopher Scully | M | 53 | 20 years | |
| Bruce Curtis Crosby | M | - | 2 years | |
| Hua Gong | M | 57 | 10 years | |
| Paulash Mohsen | M | - | 14 years | |
| Deborah Baron | F | 55 | - | |
| Mark J. Taisey | M | - | 5 years | |
| Muriel Cottard | M | - | 4 years | |
| Adrian Otte | M | - | 6 years | |
| David DeMicco | M | - | 22 years | |
| Eduardo Von Pervieux | M | - | 6 years | |
| Warren R. Winter | M | - | 15 years | |
| Alexander Polinsky | M | 67 | 8 years | |
| Richard G. Minicus | M | - | - | |
| John W. Poyhonen | M | 64 | 7 years | |
| James L. Freddo | M | 69 | 3 years | |
| Louis Yu | M | 73 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 1 years |
| Lisa Ricciardi | F | 64 | - | |
| Walter S. Hauck | M | 64 | 13 years | |
| Lance Berman | M | 53 | 6 years | |
| Kenneth Bahrt | M | 71 | 4 years | |
| Ken Keyong Ren | M | 64 | 2 years | |
| Claus Egstrand | M | 63 | 3 years | |
| John F. Niblack | M | 85 | 35 years | |
| William R. Howell | M | 88 | 9 years | |
| Jonathan R. McGrath | M | - | 5 years | |
| Robert Zerbe | M | 73 | 7 years | |
| William Sigmund | M | - | 4 years | |
| Jeffrey Ives | M | 73 | 8 years | |
| Linda Armstrong | M | 61 | 6 years | |
| Brian Goldberg | M | 50 | 2 years | |
| James New | M | 70 | 5 years | |
| William H. D. Horton | M | - | 1 years | |
| Victor Micati | M | 83 | 34 years | |
| Gary Seelhorst | M | 52 | 8 years | |
| Frank Sciavolino | M | 83 | 35 years | |
| Julie A. Olson | M | - | 19 years | |
| Eliot Forster | M | 58 | 11 years | |
| William J. Slichenmyer | M | 66 | 7 years | |
| Jay T. Goodwin | M | - | - | |
| Tim Bertram | M | 68 | 5 years | |
| Kathleen Boziwick | F | - | - | |
| Michael Loechel | M | - | 11 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 89 | 89.00% |
| Canada | 11 | 11.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Michael T. Sweeney
- Personal Network
